Načítá se...
COVID-19: Analysis of Drug Repositioning Practice
An outbreak of a new coronavirus disease (COVID-19) in China in December 2019 became the epicenter for the spread of a global pandemic. The SARS-CoV-2 coronavirus causes a cascade of respiratory diseases similar to severe acute respiratory syndrome (SARS). Currently, there is no effective, specific,...
Uloženo v:
| Vydáno v: | Pharm Chem J |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7797491/ https://ncbi.nlm.nih.gov/pubmed/33456092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11094-021-02308-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|